A carregar...
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
The CXCR4 receptor and its ligand CXCL12 (also named stromal cell-derived factor 1, SDF1) have a critical role in chemotaxis and homing, key steps in cancer metastasis. Although myofibroblasts expressing CXCL12 are associated with the presence of axillary metastases in HER2 breast cancers (BC), the...
Na minha lista:
| Publicado no: | Oncogene |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5340801/ https://ncbi.nlm.nih.gov/pubmed/27669438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2016.284 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|